Ipsen has taken rights to PPAR agonist elafibranor as a treatment for primary biliary ... Intercept Pharma's FXR agonist obeticholic acid – still a hopeful for NASH despite being rejected ...

Half-a-dozen companies are racing to develop a treatment to halt the progress of ... though Intercept’s Ocaliva (obeticholic acid, an FXR agonist) and Genfit’s elafibranor (PPAR α and δ ...

The global antacids market is on track for substantial expansion, with projections indicating a rise from USD 6,971.2 million ...

People with acid reflux often rely on acid-reducing medications to ease symptoms. Depending on the severity of your symptoms, ...

Certain drinks may soothe acid reflux symptoms and promote better digestion. Here are some expert-recommended options: ...

Zydus Lifesciences announced that Usnoflast, a treatment for amyotrophic lateral sclerosis (ALS), has received Orphan Drug Designation from the US FDA. This designation supports the development of ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...

Acid reflux is a condition in which acid from ... the Sholtz-Leeds Professor of Medicine and director of the Division of Gastroenterology and Hepatology at NYU Langone Health, told The Post.

A transcutaneous electrical stimulation system (TESS) is effective in reducing both symptoms and esophageal acid exposure time in patients with gastroesophageal reflux disease (GERD), according to a ...

Alkaline water has become very popular lately. Many people call it a miracle cure for different health problems, especially those related to acidity. Some believe it can improve hydration ...

A study published in the National Library of Medicine notes that gallstone disease is more prevalent in certain genetic groups and those with diets high in fat. Symptoms can mimic acid reflux ...